Rocky Mountain Cancer

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Pancreatic cancer

Running trials

• Active, not recruiting

  Phase 3 Study of Daraxonrasib (RMC-6236) in Patients With Previously Treated Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

  NCT06625320· Phase 3· Revolution Medicines, Inc.· Source